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Speculations are finally over, the time for real data has initiated. 
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In this issue of Fertility and Sterility, Cobo et al. present a huge case series of women with 
endometriosis undergoing fertility preservation (1). Specifically, they report on 1,044 women who 
were diagnosed with endometriosis and who decided to bank their oocytes. The most striking result 
of this contribution is the high rate of women coming back to thaw their gametes (43%). 
Considering that this rate is expected to increase further by extending the length of follow-up, one 
may reasonably infer that the ultimate number needed to be treated (NNT) will be below 2. 
Noteworthy, if we also consider the high reported rate of success of the procedure (46% of those 
who thawed their oocytes had a live birth), the NNT for a live birth would be about 5 (100 / 0.43 * 
0.46). At prima faces, these NNTs appears very attractive. The authors should be commended for 
this impressive and pivotal study.  
Over the last two decades, a growing and consistent body of evidence has documented the 
detrimental effects of surgery for ovarian endometriomas. As a result, indications to surgery have 
shrunk (2). In this scenario, it is also not surprising that the issue of fertility preservation in women 
with endometriomas has received growing attention (3). To note, given the high rate of infertility 
associated to the disease, the interest has spread beyond ovarian endometriomas and has extended to 
endometriosis in general (if a woman will ultimately need IVF, it would be obviously better to store 
eggs at a younger age). However, up to now, evidence has been extremely limited (4). Indeed, prior 
to the contribution of Cobo et al. (1), only few case reports and small case series were published 
(4). The debate on the opportunity to perform fertility preservation in women with endometriosis 
was inevitably theoretical. In this context, the paper from Cobo et al. represents a milestone on this 
important argument. After years of speculations, we finally have more solid data on which 
developing thoughts and discussions. 
On the other hand, systematically recommending oocytes banking in women with endometriosis is 
premature. Endometriosis is a relatively common disease and we need more robust evidence prior 
to plea for fertility preservation in affected women. Egg banking is expensive and exposes women 
to some clinical risks. Advocating for systematic fertility preservation in affected women can cause 
wastage of resources and exposure of patients to undue risks. There is the mandatory need for 
robust cost-effectiveness and cost-beneficial analyses. In this context, one of the most crucial point 
is disentangling the magnitude of the benefit. Cobo et al. reported that 43% thawed their eggs and 
46% of them achieved a live birth. However, these rates do not represent the real effectiveness. 
Indeed, we cannot disentangle the proportion of women who would have achieved anyhow the 
pregnancy with a post-surgical fresh cycle, thus without egg banking. The focus should be on the 
incremental benefit, not on the mere rate of achieved live births. Of relevance here is that, in the 
study of Cobo et al., 39% of the women who failed to become pregnant with frozen eggs and who 
subsequently continued with fresh cycles achieved a pregnancy. The real benefit that we have to 
extrapolate is the absolute difference in terms of live births between women who stored their eggs 
and those who did not. The study of Cobo et al. is not informative on this point. In addition, one has 
to emphasize that the high rate of patients thawing their eggs (43%) and the short period of time 
between storing and thawing (a mean time of only 1.5 years) suggest that a large proportion of the 
included women did not undergo proper fertility preservation but, conversely, the egg freezing was 
part of a strategy of infertility treatment. In other words, they may have stored their eggs once they 
were already infertile but had to undergo surgery. This is clearly recognized by the authors 
themselves in the discussion. Infer the rate of use observed in these women to the more general 
population of women with endometriosis who are not interested in pregnancy seeking at the time of 
diagnosis may over-estimate the benefits of fertility preservation.  
Several other related issues remain to be addressed. In our opinion, one of the most critical is 
identifying women with endometriosis who have higher chances to be infertile in their future. This 
would consent to restrict the recommendation for oocytes freezing to the subgroup of women with 
the highest chances of thawing their eggs, actually improving the cost-beneficial balance. Some 
validated tools are available to predict pregnancy after surgery (5). However, they are based on 
surgical findings and they are validated only for operated women who start seeking pregnancy 
immediately after surgery. We would conversely need an algorithm to be used before surgery 
(relying on symptoms and imaging information) that could also provide reliable prediction for 
future fertility (in order to properly counsel also young women who are not yet interested in 
childbearing). 
In conclusion, we would really like to thank Cobo et al. for their contribution, also on behalf of the 
whole scientific community and of women with the disease. The first stone is laid. However, there 
is now the need to build a robust castle. The ultimate aim is identifying in advance women who will 
really benefit from fertility preservation in order to render oocytes freezing cost-beneficial. This 
step is essential to claim for public health system or insurance coverage and thus to avoid inequities. 
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